Celldex Therapeutics
CLDX
#5119
Rank
NZ$2.71 B
Marketcap
NZ$40.85
Share price
-0.36%
Change (1 day)
-7.11%
Change (1 year)

Earnings for Celldex Therapeutics (CLDX)

Earnings in 2025 (TTM): -NZ$0.45 Billion

According to Celldex Therapeutics's latest financial reports the company's current earnings are NZ$2.6 Million. In 2024 the company made an earning of -NZ$0.33 Billion a decrease over its 2023 earnings that were of -NZ$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Celldex Therapeutics from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.45 Billion36.4%
2024 -NZ$0.33 Billion37.34%
2023 -NZ$0.24 Billion32.63%
2022 -NZ$0.18 Billion54.88%
2021 -NZ$0.12 Billion39.49%
2020 -NZ$82.32 Million-9.08%
2019 -NZ$90.54 Million-28.64%
2018 -NZ$0.13 Billion-30.11%
2017 -NZ$0.19 Billion-17.75%
2016 -NZ$0.23 Billion4.5%
2015 -NZ$0.22 Billion4.09%
2014 -NZ$0.21 Billion51.57%
2013 -NZ$0.14 Billion40.1%
2012 -NZ$95.56 Million
2010 -NZ$2.08 Million-96.59%
2009 -NZ$60.78 Million
2006 -NZ$37.14 Million
2004 -NZ$22.56 Million15.75%
2003 -NZ$19.49 Million-18.69%
2002 -NZ$23.97 Million-41.22%
2001 -NZ$40.77 Million59%
2000 -NZ$25.64 Million27.65%
1999 -NZ$20.09 Million53.12%
1998 -NZ$13.12 Million2.6%
1997 -NZ$12.79 Million-33.62%
1996 -NZ$19.27 Million-1.69%
1995 -NZ$19.6 Million22.92%
1994 -NZ$15.94 Million-0%
1993 -NZ$15.94 Million
1991 -NZ$9.8 Million90.32%
1990 -NZ$5.15 Million10.71%
1989 -NZ$4.65 Million833.33%
1988 -NZ$0.5 Million-400%
1987 NZ$0.16 M-125%
1986 -NZ$0.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$19.67 B-4,725.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.68 B-3,317.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$15.47 B-3,738.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
-NZ$4.66 Million-98.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-NZ$1.32 Billion 208.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$34.3 M-108.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.27 B-164.51%๐Ÿ‡บ๐Ÿ‡ธ USA